The outpatient management of low-risk febrile patients with neutropenia: risk assessment over the telephone

被引：0
|
作者：
Toshiro Mizuno
Noriyuki Katsumata
Hirofumi Mukai
Chikako Shimizu
Masashi Ando
Toru Watanabe
机构：
[1] National Cancer Center Hospital,Division of Medical Oncology
[2] Mie University Hospital,Department of Medical Oncology
来源：
Supportive Care in Cancer | 2007年 / 15卷
关键词：
Low-risk; Febrile patients with neutropenia; Outpatient therapy; Oral ciprofloxacin; Risk assessment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：287 / 291
页数：4
相关论文
共 50 条
  • [31] Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children-a systematic review of prospective trials
    Manji, A.
    Beyene, J.
    Dupuis, L. L.
    Phillips, R.
    Lehrnbecher, T.
    Sung, L.
    SUPPORTIVE CARE IN CANCER, 2012, 20 (06) : 1135 - 1145
  • [32] Risk scores for outpatient management of febrile neutropenia: Is the MASCC slipping?
    Cooksley, Tim
    Ahn, Shin
    Knight, Thomas
    Rice, Terry W.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 50 : E35 - E36
  • [33] Treating low-risk febrile neutropenia: Jenny's story
    Phillips, R.
    Skinner, R.
    Chisholm, J. C.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (01) : 7 - 8
  • [34] Single-Agent, Broad-Spectrum Fluoroquinolones for the Outpatient Treatment of Low-Risk Febrile Neutropenia
    Cooper, Maryann R.
    Durand, Cheryl R.
    Beaulac, Matthew T.
    Steinberg, Michael
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (09) : 1094 - 1102
  • [35] Economic and resource utilization analysis of outpatient management of fever and neutropenia in low-risk pediatric patients with cancer
    Mullen, CA
    Petropoulos, D
    Roberts, WM
    Rytting, M
    Zipf, T
    Chan, KW
    Culbert, SJ
    Danielson, M
    Jeha, SS
    Kuttesch, JF
    Rolston, KV
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (03) : 212 - 218
  • [36] Outpatient antibiotic therapy for febrile episodes in low-risk neutropenic patients with cancer
    Escalante, CP
    Rubenstein, EB
    Rolston, KVI
    CANCER INVESTIGATION, 1997, 15 (03) : 237 - 242
  • [37] Efficacy and Safety of Sitafloxacin in Treating Low-risk Febrile Neutropenia in Patients with Lung Cancer
    On, Rintaro
    Matsumoto, Takemasa
    Ebi, Noriyuki
    Doi, Seiji
    Ishii, Hiroshi
    Furugen, Makoto
    Fujita, Jiro
    Ide, Maako
    Kishimoto, Junji
    Okamoto, Isamu
    Fujita, Masaki
    JMA JOURNAL, 2022, 5 (03): : 334 - 340
  • [38] Barriers to Protocol-led Early Discharge of Low-risk Febrile Neutropenia Patients
    Day, E.
    Kim, S.
    Hughes-Davies, L.
    CLINICAL ONCOLOGY, 2014, 26 (08) : 516 - 516
  • [39] Analysis and treatment of low-risk febrile neutropenia (LRFN) in cancer patients with solid tumours
    Varlan, GV
    Averina, NA
    Petukhova, IN
    Dmitrieva, NV
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S232 - S232
  • [40] MANAGEMENT OF FEBRILE NEUTROPENIA AT OUTPATIENT CLINIC: RISK SELF-ASSESSMENT BY SIMPLIFIED SCORING SYSTEM
    Mizuno, T.
    Kitano, S.
    Saito, K.
    Tamaru, S.
    Yamashita, Y.
    Kageyama, S.
    Katayama, N.
    ANNALS OF ONCOLOGY, 2010, 21 : 382 - 383
12345